Comprehensive Analysis of Molecular Biologic Characteristics of Pancreatic Ductal Adenocarcinoma Concomitant with Intraductal Papillary Mucinous Neoplasm
Masahiro Tsujimae,Atsuhiro Masuda,Takuya Ikegawa,Takeshi Tanaka,Jun Inoue,Hirochika Toyama,Keitaro Sofue,Hisahiro Uemura,Shinya Kohashi,Noriko Inomata,Kae Nagao,Shigeto Masuda,Shohei Abe,Masanori Gonda,Kohei Yamakawa,Shigeto Ashina,Yasutaka Yamada,Shunta Tanaka,Ryota Nakano,Arata Sakai,Takashi Kobayashi,Hideyuki Shiomi,Maki Kanzawa,Tomoo Itoh,Takumi Fukumoto,Yoshihide Ueda,Yuzo Kodama
DOI: https://doi.org/10.1245/s10434-022-11704-z
IF: 4.339
2022-05-23
Annals of Surgical Oncology
Abstract:BackgroundPancreatic ductal adenocarcinoma (PDAC) concomitant with intraductal papillary mucinous neoplasm (IPMN) is defined as PDAC occurring apart from IPMN. This study comprehensively investigated the molecular biologic characteristics of PDAC concomitant with IPMN in major genetic alterations, tumor microenvironment, and prognosis by contrast with those of conventional PDAC.MethodsThe study retrospectively reviewed the data of 158 surgically resected PDAC patients. The driver gene alteration status (KRAS, TP53, CDKN2A, SMAD4, and GNAS) together with the immune and fibrotic status in tumor was evaluated. The prognosis of PDAC concomitant with IPMN and that of conventional PDAC also were compared.ResultsNo statistically significant difference was found between PDAC concomitant with IPMN and conventional PDAC in the alteration frequency analysis of the major driver genes and the immune and fibrotic status in the tumor microenvironment. Overall survival and disease-free survival between patients who had PDAC concomitant with IPMN and those who had conventional PDAC did not show statistically significant differences in propensity-matched subjects. Furthermore, the co-existence of IPMN was not a poor prognostic factor in the multivariable-adjusted Cox proportional hazards model (hazard ratio, 0.95; 95 % confidence interval, 0.51–1.78).ConclusionsIn this study, PDAC concomitant with IPMN had tumor characteristics similar to those of conventional PDAC in terms of the major driver gene alterations, tumor microenvironment, and prognosis.
oncology,surgery